Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: An overview

被引:138
|
作者
Matson, Johnny L. [1 ]
Neal, Daniene [1 ]
机构
[1] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA
关键词
Psychotropic; Challenging behaviors; Intellectual disability; SELF-INJURIOUS-BEHAVIOR; MENTALLY-RETARDED CHILDREN; DOUBLE-BLIND; LONG-TERM; DRUG USE; RISPERIDONE TREATMENT; OPEN-LABEL; HALOPERIDOL TREATMENT; DISRUPTIVE BEHAVIORS; MALADAPTIVE BEHAVIOR;
D O I
10.1016/j.ridd.2008.08.007
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
Challenging behaviors in persons with intellectual disabilities are primary target for treatment in mental health clinics and institutions. Furthermore, an increasing number of people are receiving psychotropic medications for the management of their challenging behaviors. Many people are often treated with high doses of multiple psychotropic medications for extended periods of time with little or no data collected to determine treatment efficacy. Similarly, data demonstrating treatment effectiveness is at best questionable at this time. it is for these reasons that controversy exists regarding the use of psychotropic medication for challenging behaviors. The purpose of this paper was to summarize past and current studies of drug related interventions for challenging behaviors for persons with intellectual disabilities. Based on the results of this review, the effectiveness of psychotropic medications in managing challenging behaviors is best described as minimal and a need exists for controlled studies of higher scientific quality in this area. Considering alternative psychologically based interventions and careful functional assessments appear to be advisable. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:572 / 586
页数:15
相关论文
共 50 条